Boxer Capital Management LLC 13D and 13G filings for Fate Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-25 9:37 pm Purchase | 2024-10-10 | 13G | Fate Therapeutics, Inc. FATE | Boxer Capital Management LLC | 4,960,910 4.400% | 4,960,910 (New Position) | Filing |